Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Vantard

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
BMC Cancer|November 10, 2011
Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costsFlorence Ranchon, Gilles Salles, Hans-Martin Späth, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|March 16, 2016
SIMulation of Medication Error induced by Clinical Trial drug labeling: the SIMME-CT studyCecile Dollinger, Vérane Schwiertz, Laura Sarfati, et al.
Hematological Oncology|October 7, 2017
Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?Florence Ranchon, Nicolas Vantard, Emilie Henin, et al.
Bulletin Du Cancer|February 27, 2017
[Evolution of reimbursement of high-cost anticancer drugs: Financial impact within a university hospital]Amandine Baudouin, Emilie Fargier, Ariane Cerruti, et al.
Clinical Therapeutics|March 12, 2014
Administration of anticancer drugs: exposure in hospital nursesCatherine Rioufol, Florence Ranchon, Vérane Schwiertz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2016
Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell TransplantationMichael Philippe, Florence Ranchon, Lila Gilis, et al.
BMC Pharmacology & Toxicology|January 15, 2014
Hypersensitivity to oxaliplatin: clinical features and risk factorsMarie Parel, Florence Ranchon, Audrey Nosbaum, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 8, 2021
Immunosuppression medication adherence after allogeneic hematopoietic stem cell transplant: Impact of a specialized clinical pharmacy programFlorent Charra, Michael Philippe, Chloé Herledan, et al.
Plos One|December 4, 2020
Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients' knowledge to manage adverse effectsJuliette Périchou, Florence Ranchon, Chloé Herledan, et al.
Annals of Hematology|October 11, 2017
SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphomaEmilie Fargier, Florence Ranchon, Laure Huot, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
BMC Cancer|November 10, 2011
Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costsFlorence Ranchon, Gilles Salles, Hans-Martin Späth, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|March 16, 2016
SIMulation of Medication Error induced by Clinical Trial drug labeling: the SIMME-CT studyCecile Dollinger, Vérane Schwiertz, Laura Sarfati, et al.
Hematological Oncology|October 7, 2017
Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?Florence Ranchon, Nicolas Vantard, Emilie Henin, et al.
Bulletin Du Cancer|February 27, 2017
[Evolution of reimbursement of high-cost anticancer drugs: Financial impact within a university hospital]Amandine Baudouin, Emilie Fargier, Ariane Cerruti, et al.
Clinical Therapeutics|March 12, 2014
Administration of anticancer drugs: exposure in hospital nursesCatherine Rioufol, Florence Ranchon, Vérane Schwiertz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2016
Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell TransplantationMichael Philippe, Florence Ranchon, Lila Gilis, et al.
BMC Pharmacology & Toxicology|January 15, 2014
Hypersensitivity to oxaliplatin: clinical features and risk factorsMarie Parel, Florence Ranchon, Audrey Nosbaum, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 8, 2021
Immunosuppression medication adherence after allogeneic hematopoietic stem cell transplant: Impact of a specialized clinical pharmacy programFlorent Charra, Michael Philippe, Chloé Herledan, et al.
Plos One|December 4, 2020
Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients' knowledge to manage adverse effectsJuliette Périchou, Florence Ranchon, Chloé Herledan, et al.
Annals of Hematology|October 11, 2017
SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphomaEmilie Fargier, Florence Ranchon, Laure Huot, et al.
Pageof 3